Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - TOTAL ASSETS
Total Assets ALNY - Alnylam Pharmaceuticals, Inc.
3.83 B
LAST VALUE
2.53%
2 YEAR CAGR
19.45%
5 YEAR CAGR
24.72%
10 YEAR CAGR